Search results
Results From The WOW.Com Content Network
Metanephric adenoma (MA) is a rare, benign tumour of the kidney, that can have a microscopic appearance similar to a nephroblastoma (Wilms tumours), [1] or a papillary renal cell carcinoma. It should not be confused with the pathologically unrelated, yet similar sounding, mesonephric adenoma .
Metanephric dysplastic hematoma of the sacral region (MDHSR) has been described by Cozzutto and Lazzaroni-Fossati in 1980, [1] by Posalaki et al. in 1981 [2] and by Cozzutto et al. in 1982. [3] Three additional cases were seen by Finegold.
Nephrogenic adenoma is a benign growth typically found in the urinary bladder. It is thought to result from displacement and implantation of renal tubular cells, as this entity in kidney transplant recipients has been shown to be kidney donor derived. [1] This entity should not be confused with the similar-sounding metanephric adenoma.
Histopathologic types of kidney tumor, with relative incidences and prognoses. Cystic nephroma is seen at bottom right in pie chart. cystic partially differentiated nephroblastoma; cystic standard nephroblastoma (cystic Wilm's tumor) cystic mesoblastic nephroma; cystic renal cell carcinoma; other renal cysts
Here, first a fertilised egg implants into the uterus, but some cells around the fetus (the chorionic villi) do not develop properly. The pregnancy is not viable, and the normal pregnancy process turns into a benign tumour. There are two subtypes of hydatidiform mole: complete hydatidiform mole, and partial hydatidiform mole. [citation needed]
Thus, the life of a fetus in fetu is akin to that of a tumor in that its cells remain viable by way of normal metabolic activity. However, without the gestational conditions in utero with the amnion and placenta , a fetus in fetu can develop into, at best, an especially well differentiated teratoma ; or, at worst, a high-grade metastatic ...
Tumor Biology (also Tumour Biology) is a bimonthly peer-reviewed open access medical journal covering clinical and experimental oncology. It was established in 1980 as Oncodevelopmental Biology and Medicine, obtaining its current name in 1984. It is owned by the International Society of Oncology and BioMarkers, of which it is the official journal.
Help; Learn to edit; Community portal; Recent changes; Upload file; Special pages